Xiaolong Wu

1.6k total citations
70 papers, 723 citations indexed

About

Xiaolong Wu is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaolong Wu has authored 70 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 23 papers in Pathology and Forensic Medicine and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaolong Wu's work include Lymphoma Diagnosis and Treatment (18 papers), Ferroptosis and cancer prognosis (7 papers) and Gastric Cancer Management and Outcomes (7 papers). Xiaolong Wu is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Ferroptosis and cancer prognosis (7 papers) and Gastric Cancer Management and Outcomes (7 papers). Xiaolong Wu collaborates with scholars based in China, Ethiopia and United States. Xiaolong Wu's co-authors include Xiangyu Gao, Jiafu Ji, Ziyu Li, Ting Guo, Xiaohuan Tang, Xiaofang Xing, Xiaofang Xing, Mingzhi Zhang, Zhonghua Ma and You Shuai and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Xiaolong Wu

63 papers receiving 717 citations

Peers

Xiaolong Wu
Qiang Zuo China
Xiao‐Peng Tian China
Can Gong United States
Yangfan Lv China
Ghil Suk Yoon South Korea
Yanfeng Xi China
Qi Song China
Ryan M. Naylor United States
Feng Tang China
Woon Yong Jung South Korea
Qiang Zuo China
Xiaolong Wu
Citations per year, relative to Xiaolong Wu Xiaolong Wu (= 1×) peers Qiang Zuo

Countries citing papers authored by Xiaolong Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Wu more than expected).

Fields of papers citing papers by Xiaolong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Wu. The network helps show where Xiaolong Wu may publish in the future.

Co-authorship network of co-authors of Xiaolong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Wu. A scholar is included among the top collaborators of Xiaolong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Wu. Xiaolong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xiaolong, Liang Yu, Yunwei Li, et al.. (2025). High-performance 2D NaNbO3/PVDF piezoelectric nanogenerators for energy harvesting and wearable electronics. Journal of Alloys and Compounds. 1038. 182747–182747. 3 indexed citations
2.
Zhang, Jiong, et al.. (2024). Characteristics of Noise Caused by Trains Passing on Urban Rail Transit Viaducts. Sustainability. 17(1). 94–94. 2 indexed citations
3.
Feng, Xiaoyan, Mengke Fan, Qingjiang Chen, et al.. (2024). Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma. Frontiers in Immunology. 15. 1481301–1481301.
4.
Cao, Qinchen, Xinxin Wang, Jie Liu, et al.. (2024). ICBP90, an epigenetic regulator, induces DKK3 promoter methylation, promotes glioma progression, and reduces sensitivity to cis-platinum. Experimental Cell Research. 436(2). 113976–113976.
5.
Wen, Xin, Hui Yu, Lei Zhang, et al.. (2024). The relationship and clinical significance of serum cytokine expression level and skin pruritus in patients with Hodgkin lymphoma and angioimmunoblastic T-cell lymphoma. International Immunopharmacology. 131. 111777–111777. 1 indexed citations
6.
Zhang, Xudong, Xiaoyan Feng, Meng Dong, et al.. (2023). Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma. Cancer Medicine. 12(7). 8134–8143. 7 indexed citations
7.
Wu, Xiaolong, Xudong Zhang, Xin Li, et al.. (2023). The experience of diagnosis and treatment for TAFRO syndrome. Annals of Hematology. 102(12). 3515–3520. 4 indexed citations
8.
Tang, Xiaohuan, Xiaolong Wu, Yiding Wang, et al.. (2023). Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. International Journal of Molecular Sciences. 24(15). 12192–12192. 10 indexed citations
9.
Shi, Jinyao, Zhouqiao Wu, Xiaolong Wu, et al.. (2022). Early diagnosis of anastomotic leakage after colorectal cancer surgery using an inflammatory factors-based score system. BJS Open. 6(3). 11 indexed citations
10.
Tang, Xiaohuan, Xiaolong Wu, Ting Guo, et al.. (2022). Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer. Frontiers in Oncology. 12. 808817–808817. 5 indexed citations
11.
Yu, Hui, Xiaorui Fu, Lei Zhang, et al.. (2021). Clinical analysis of patients with primary and secondary extranodal natural killer/T‐cell lymphoma of central nervous system. Hematological Oncology. 41(2). 267–274. 2 indexed citations
12.
13.
Zhang, Lei, Ling Li, Xin Li, et al.. (2020). <p>Effective Treatment with PD-1 Antibody, Chidamide, Etoposide, and Thalidomide (PCET) for Relapsed/Refractory Natural Killer/T-Cell Lymphoma: A Report of Three Cases</p>. OncoTargets and Therapy. Volume 13. 7189–7197. 11 indexed citations
14.
Wu, Xiaolong, et al.. (2020). Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Chinese Journal of Integrative Medicine. 26(5). 324–329. 3 indexed citations
15.
Li, Ziyu, Xiaolong Wu, Xiangyu Gao, et al.. (2020). Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma. British Journal of Cancer. 124(5). 942–950. 1 indexed citations
16.
17.
Cui, Yingying, Xin Li, Zhenchang Sun, et al.. (2015). Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma. Leukemia & lymphoma. 56(9). 2613–2618. 11 indexed citations
18.
19.
Wu, Jingjing & Xiaolong Wu. (2014). Clinical significance of BRCA1 and Ki-67 expression in breast cancer. 26(1). 1–5. 1 indexed citations
20.
Sun, Zhenchang, Xin Li, Xiaolong Wu, et al.. (2014). Clinical analysis of chronic lung injury in patients with non-Hodgkin lymphoma after CHOP chemotherapy. Tumor Biology. 35(12). 12601–12605.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiang Zuo Breakdown of academic impact, for papers by Xiao‐Peng Tian Breakdown of academic impact, for papers by Can Gong Breakdown of academic impact, for papers by Yangfan Lv Breakdown of academic impact, for papers by Ghil Suk Yoon Breakdown of academic impact, for papers by Yanfeng Xi Breakdown of academic impact, for papers by Qi Song Breakdown of academic impact, for papers by Ryan M. Naylor Breakdown of academic impact, for papers by Feng Tang Breakdown of academic impact, for papers by Woon Yong Jung
Rankless by CCL
2026